Cargando…

Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy

BACKGROUND: Patients with neuroimmunological conditions such as multiple sclerosis (MS) often receive disease-modifying therapies (DMTs) or immunosuppressants which may reduce the response to vaccines. BNT162b2 (Pfizer-BioNTech) is the first COVID-19 vaccine authorized in Italy. Its clinical efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giossi, Riccardo, Consonni, Alessandra, Torri Clerici, Valentina, Zito, Antonio, Rigoni, Eleonora, Antozzi, Carlo, Brambilla, Laura, Crisafulli, Sebastiano Giuseppe, Bellino, Antonella, Frangiamore, Rita, Bonanno, Silvia, Vanoli, Fiammetta, Ciusani, Emilio, Corsini, Elena, Andreetta, Francesca, Baggi, Fulvio, Tramacere, Irene, Mantegazza, Renato, Conte, Antonella, Bergamaschi, Roberto, Confalonieri, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614185/ https://www.ncbi.nlm.nih.gov/pubmed/35216790 http://dx.doi.org/10.1016/j.msard.2021.103415

Ejemplares similares

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy
por: Iacomino, Nicola, et al.
Publicado: (2022)

Iatrogenic Kaposi’s sarcoma in myasthenia gravis: learnings from two case reports
por: Frangiamore, Rita, et al.
Publicado: (2021)

Complement Inhibition for the Treatment of Myasthenia Gravis
por: Mantegazza, Renato, et al.
Publicado: (2020)

Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study
por: Bonanno, Silvia, et al.
Publicado: (2018)

Development and validation of the Myasthenia Gravis TeleScore (MGTS)
por: Pasqualin, F., et al.
Publicado: (2022)

miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids
por: Bortone, Federica, et al.
Publicado: (2020)

Current and emerging therapies for the treatment of myasthenia gravis
por: Mantegazza, Renato, et al.
Publicado: (2011)

Animal models of myasthenia gravis: utility and limitations
por: Mantegazza, Renato, et al.
Publicado: (2016)

When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
por: Mantegazza, Renato, et al.
Publicado: (2018)

From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
por: Mantegazza, Renato, et al.
Publicado: (2020)

Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis
por: Antozzi, Carlo, et al.
Publicado: (2023)

CD146(+) Pericytes Subset Isolated from Human Micro-Fragmented Fat Tissue Display a Strong Interaction with Endothelial Cells: A Potential Cell Target for Therapeutic Angiogenesis
por: Manocha, Ekta, et al.
Publicado: (2022)

Face yourself: The social neuroscience of mirror gazing
por: Tramacere, Antonella
Publicado: (2022)

Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?
por: Cavalcante, Paola, et al.
Publicado: (2017)

Determination of the Molecular Weight of Low-Molecular-Weight Heparins by Using High-Pressure Size Exclusion Chromatography on Line with a Triple Detector Array and Conventional Methods
por: Bisio, Antonella, et al.
Publicado: (2015)

Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats
por: Consonni, Alessandra, et al.
Publicado: (2018)

A novel mind‐set in primate experimentation: Implications for primate welfare
por: Tramacere, Antonella, et al.
Publicado: (2021)

“Natural Laboratory Complex” for novel primate neuroscience
por: Iriki, Atsushi, et al.
Publicado: (2022)

Therapeutic Effect of Bifidobacterium Administration on Experimental Autoimmune Myasthenia Gravis in Lewis Rats
por: Rinaldi, Elena, et al.
Publicado: (2019)

Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program
por: Gastaldi, Matteo, et al.
Publicado: (2020)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

miRNA in spinal muscular atrophy pathogenesis and therapy
por: Magri, Francesca, et al.
Publicado: (2017)

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization
por: Iacomino, Nicola, et al.
Publicado: (2023)

Immunoblot analysis of antiAChR antibodies in myasthenia gravis
por: Mantegazza, R., et al.
Publicado: (1988)

Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups
por: Donninelli, Gloria, et al.
Publicado: (2021)

Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1
por: Vanoli, Fiammetta, et al.
Publicado: (2015)

An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
por: Nava, Sara, et al.
Publicado: (2012)

NEWS2 is a valuable tool for appropriate clinical management of COVID-19 patients
por: Rigoni, Marta, et al.
Publicado: (2021)

Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients
por: Bonanno, Silvia, et al.
Publicado: (2020)

The Role of Adhesion Molecules and Extracellular Vesicles in an In Vitro Model of the Blood–Brain Barrier for Metastatic Disease
por: Vasco, Chiara, et al.
Publicado: (2023)

The Emotional Modulation of Facial Mimicry: A Kinematic Study
por: Tramacere, Antonella, et al.
Publicado: (2018)

Inflammation and Epstein-Barr Virus Infection Are Common Features of Myasthenia Gravis Thymus: Possible Roles in Pathogenesis
por: Cavalcante, Paola, et al.
Publicado: (2011)

Application of the Intermittency Ratio Metric for the Classification of Urban Sites Based on Road Traffic Noise Events
por: Brambilla, Giovanni, et al.
Publicado: (2019)

Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors
por: Cugno, Massimo, et al.
Publicado: (2021)

Management of severe acute exacerbations of COPD: an updated narrative review
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment
por: Bonanno, Silvia, et al.
Publicado: (2022)

Overall Efficacy and Safety of Safinamide in Parkinson’s Disease: A Systematic Review and a Meta-analysis
por: Giossi, Riccardo, et al.
Publicado: (2021)

A model based on intensity of medical care may improve outcomes for internal medicine patients in Italy
por: Torri, Emanuele, et al.
Publicado: (2019)

Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project
por: Colombo, Cinzia, et al.
Publicado: (2016)

Lymphadenopathy after BNT162b2 Covid-19 Vaccine: Preliminary Ultrasound Findings
por: Granata, Vincenza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fm2vmv2et8k5t9cj2fj4qosvmd